J&J to acquire V-Wave for up to $1.7 billion in play for heart-failure device
The device, which can be inserted through a minimally invasive catheter-based procedure, received FDA Breakthrough Device Designation in 2019 and has the potential to become the first device of its kind to market, Johnson & Johnson said.
